Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety

PURPOSE: To evaluate the efficacy of cytokine-induced killer (CIK) cell therapy in the treatment of hepatocellular carcinoma. MATERIALS AND METHODS: Randomized phase II and III trials on CIK cell-based therapy were identified by electronic searches using a combination of "hepatocellular carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yue, Xu, Ying-Chun, Tang, Lei, Zhang, Zan, Wang, Jian, Wang, Hong-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514101/
https://www.ncbi.nlm.nih.gov/pubmed/23210562
http://dx.doi.org/10.1186/2162-3619-1-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514101/
https://www.ncbi.nlm.nih.gov/pubmed/23210562
http://dx.doi.org/10.1186/2162-3619-1-11

Ejemplares similares